RussellPachynskiMD
Oncology • Saint Louis, MOGenitourinary Oncology, Hematologic Oncology
Associate Professor of Medicine Division of Oncology
Dr. Pachynski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Summary
- I have experience and expertise in tumor immunology and immunotherapy in the GU malignancies, with a focus on prostate cancer. My lab studies leukocyte trafficking with a goal of favorable modulation in the context of the tumor microenvironment for therapeutic purposes.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2011- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
University of Wisconsin School of Medicine & Public HealthClass of 2003
Stanford UniversityB.S., Biology, 1990 - 1994
Certifications & Licensure
MO State Medical License 2014 - 2025
CA State Medical License 2004 - 2024
Awards, Honors, & Recognition
- Research Scholar Grant American Cancer Society, 2023
- Prostate Cancer Foundation Team Challenge Award 2016
- Kimmel Scholar Award 2016
- Join now to see all
Clinical Trials
- Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer Start of enrollment: 2018 Sep 14
Publications & Presentations
PubMed
- 63 citationsHistopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.Yize Li, Tung-Shing M Lih, Saravana M Dhanasekaran, Rahul Mannan, Lijun Chen
Cancer Cell. 2023-01-09 - 38 citationsActive surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)Michael R. Harrison, Brian A. Costello, Nrupen A. Bhavsar, Ulka N. Vaishampayan, Sumanta K. Pal
Cancer. 2021-07-01 - 8 citationsPhase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors.David S Hong, Marcus O Butler, Russell K Pachynski, Ryan Sullivan, Partow Kebriaei
Frontiers in Oncology. 2022-01-01
Press Mentions
Physician-Scientists Receive Scholar-Innovator AwardJuly 24th, 2024- Physician-Scientists Receive Scholar-Innovator AwardJune 10th, 2024
- Physician-Scientists Receive Scholar-Innovator AwardJune 7th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
